6SNB

Structure of Coxsackievirus A10 A-particle


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 4.4 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10.

Zhao, Y.Zhou, D.Ni, T.Karia, D.Kotecha, A.Wang, X.Rao, Z.Jones, E.Y.Fry, E.E.Ren, J.Stuart, D.I.

(2020) Nat Commun 11: 38-38

  • DOI: 10.1038/s41467-019-13936-2
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • Coxsackievirus A10 (CV-A10) is responsible for an escalating number of severe infections in children, but no prophylactics or therapeutics are currently available. KREMEN1 (KRM1) is the entry receptor for the largest receptor-group of hand-foot-and-m ...

    Coxsackievirus A10 (CV-A10) is responsible for an escalating number of severe infections in children, but no prophylactics or therapeutics are currently available. KREMEN1 (KRM1) is the entry receptor for the largest receptor-group of hand-foot-and-mouth disease causing viruses, which includes CV-A10. We report here structures of CV-A10 mature virus alone and in complex with KRM1 as well as of the CV-A10 A-particle. The receptor spans the viral canyon with a large footprint on the virus surface. The footprint has some overlap with that seen for the neonatal Fc receptor complexed with enterovirus E6 but is larger and distinct from that of another enterovirus receptor SCARB2. Reduced occupancy of a particle-stabilising pocket factor in the complexed virus and the presence of both unbound and expanded virus particles suggests receptor binding initiates a cascade of conformational changes that produces expanded particles primed for viral uncoating.


    Organizational Affiliation

    Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK. dave@strubi.ox.ac.uk.,Materials and Structural Analysis, Thermo Fisher Scientific, Eindhoven, The Netherlands.,National Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Science, 100101, Beijing, China.,Diamond Light Source Ltd, Harwell Science & Innovation Campus, Didcot, OX11 0DE, UK. dave@strubi.ox.ac.uk.,Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK.,Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Headington, Oxford, OX3 7BN, UK. ren@strubi.ox.ac.uk.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Capsid protein VP1
A
298Coxsackievirus A10Mutation(s): 0 
Find proteins for Q6JKR9 (Coxsackievirus A10)
Go to UniProtKB:  Q6JKR9
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Capsid protein VP2
B
255Coxsackievirus A10Mutation(s): 0 
Find proteins for Q6JKR9 (Coxsackievirus A10)
Go to UniProtKB:  Q6JKR9
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetails
Capsid protein VP3
C
240Coxsackievirus A10Mutation(s): 0 
Find proteins for Q6JKR9 (Coxsackievirus A10)
Go to UniProtKB:  Q6JKR9
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 4.4 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
Software Package:
Software NamePurpose
PHENIXrefinement

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Medical Research Council (United Kingdom)United KingdomMR/N00065X/1
Wellcome TrustUnited Kingdom101122/Z/13/Z
Cancer Research UKUnited KingdomC375/A17721

Revision History 

  • Version 1.0: 2020-01-15
    Type: Initial release
  • Version 1.1: 2020-01-22
    Type: Database references